Document
4900000P5D700019000false--12-31Q22019000165521000.00010.0001586696005000000006951350601675216951350601675216000000200000005000000005000005000005000005000000.00010.0001500000500000000000P3Y25.0025.001.50.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.00010.0001333350048022608076643871320747405314866776514025742096930000000033335004680565807663687132014701449486675851147862075216000000003333500468056580766368713201470144948667585114786207521600000000
0001655210
2019-01-01
2019-06-29
0001655210
2019-07-26
0001655210
2019-06-29
0001655210
us-gaap:SeriesFPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesAPreferredStockMember
2018-12-31
0001655210
2018-12-31
0001655210
us-gaap:SeriesEPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesAPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesHPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesDPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesBPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesHPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesBPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesGPreferredStockMember
2019-06-29
0001655210
us-gaap:SeriesDPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesCPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesFPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesGPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesEPreferredStockMember
2018-12-31
0001655210
us-gaap:SeriesCPreferredStockMember
2019-06-29
0001655210
2019-03-31
2019-06-29
0001655210
2018-01-01
2018-06-30
0001655210
2018-04-01
2018-06-30
0001655210
us-gaap:CommonStockMember
2019-06-29
0001655210
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
2019-06-29
0001655210
2019-03-30
0001655210
us-gaap:CommonStockMember
2019-03-30
0001655210
us-gaap:CommonStockMember
2019-03-31
2019-06-29
0001655210
us-gaap:IPOMember
2019-03-31
2019-06-29
0001655210
us-gaap:AdditionalPaidInCapitalMember
2019-03-30
0001655210
us-gaap:RetainedEarningsMember
2019-06-29
0001655210
us-gaap:CommonStockMember
us-gaap:IPOMember
2019-03-31
2019-06-29
0001655210
us-gaap:CommonStockMember
2018-12-31
0001655210
us-gaap:CommonStockMember
2019-01-01
2019-03-30
0001655210
2019-01-01
2019-03-30
0001655210
us-gaap:RetainedEarningsMember
2019-03-31
2019-06-29
0001655210
us-gaap:RetainedEarningsMember
2018-12-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-30
0001655210
us-gaap:AdditionalPaidInCapitalMember
2019-06-29
0001655210
us-gaap:RetainedEarningsMember
2019-03-30
0001655210
us-gaap:AdditionalPaidInCapitalMember
us-gaap:IPOMember
2019-03-31
2019-06-29
0001655210
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-30
0001655210
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0001655210
bynd:LoanstoRelatedPartiesMember
2018-03-31
0001655210
us-gaap:CommonStockMember
2018-03-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-03-31
0001655210
us-gaap:RetainedEarningsMember
2018-01-01
2018-03-31
0001655210
us-gaap:CommonStockMember
2018-04-01
2018-06-30
0001655210
us-gaap:CommonStockMember
2018-06-30
0001655210
2017-12-31
0001655210
us-gaap:RetainedEarningsMember
2018-06-30
0001655210
us-gaap:CommonStockMember
2017-12-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2018-06-30
0001655210
bynd:LoanstoRelatedPartiesMember
2017-12-31
0001655210
2018-01-01
2018-03-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2018-04-01
2018-06-30
0001655210
2018-06-30
0001655210
2018-03-31
0001655210
us-gaap:RetainedEarningsMember
2018-03-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0001655210
us-gaap:RetainedEarningsMember
2018-04-01
2018-06-30
0001655210
us-gaap:CommonStockMember
2018-01-01
2018-03-31
0001655210
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0001655210
us-gaap:RetainedEarningsMember
2017-12-31
0001655210
bynd:LoanstoRelatedPartiesMember
2018-06-30
0001655210
us-gaap:IPOMember
2019-05-06
0001655210
us-gaap:IPOMember
2019-05-06
2019-05-06
0001655210
us-gaap:CommonStockMember
us-gaap:IPOMember
2019-05-06
0001655210
2019-05-06
2019-05-06
0001655210
us-gaap:OverAllotmentOptionMember
2019-05-06
2019-05-06
0001655210
bynd:FrozenMember
2019-01-01
2019-06-29
0001655210
bynd:FrozenMember
2018-04-01
2018-06-30
0001655210
bynd:FreshMember
2019-03-31
2019-06-29
0001655210
bynd:FreshMember
2019-01-01
2019-06-29
0001655210
bynd:FreshMember
2018-04-01
2018-06-30
0001655210
bynd:FrozenMember
2018-01-01
2018-06-30
0001655210
bynd:FrozenMember
2019-03-31
2019-06-29
0001655210
bynd:FreshMember
2018-01-01
2018-06-30
0001655210
us-gaap:ShippingAndHandlingMember
2018-04-01
2018-06-30
0001655210
us-gaap:NonUsMember
us-gaap:SalesRevenueNetMember
us-gaap:GeographicConcentrationRiskMember
2018-01-01
2018-06-30
0001655210
us-gaap:RestrictedStockUnitsRSUMember
bynd:A2018EquityIncentivePlanMember
srt:ExecutiveOfficerMember
2016-03-02
2016-03-02
0001655210
us-gaap:IPOMember
2019-06-29
0001655210
bynd:AmendedAdvisorAgreementMember
srt:AffiliatedEntityMember
2016-02-01
2016-02-28
0001655210
bynd:NonqualifiedStockOptionMember
bynd:AmendedAdvisorAgreementMember
srt:AffiliatedEntityMember
2016-02-01
2016-02-28
0001655210
bynd:AmendedAdvisorAgreementMember
srt:AffiliatedEntityMember
2016-12-01
2016-12-31
0001655210
us-gaap:NonUsMember
us-gaap:SalesRevenueNetMember
us-gaap:GeographicConcentrationRiskMember
2019-03-31
2019-06-29
0001655210
us-gaap:IPOMember
2018-12-31
0001655210
bynd:DistributorOneMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2019-03-31
2019-06-29
0001655210
bynd:DistributorTwoMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-06-29
0001655210
bynd:ConsultingAgreementMember
srt:ExecutiveOfficerMember
2019-04-08
2019-04-08
0001655210
bynd:DonaldThompsonMember
2018-01-01
2018-06-30
0001655210
us-gaap:NonUsMember
us-gaap:SalesRevenueNetMember
us-gaap:GeographicConcentrationRiskMember
2019-01-01
2019-06-29
0001655210
us-gaap:ShippingAndHandlingMember
2019-01-01
2019-06-29
0001655210
srt:MaximumMember
bynd:AmendedAdvisorAgreementMember
srt:AffiliatedEntityMember
2016-12-01
2016-12-31
0001655210
bynd:DistributorThreeMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-01-01
2018-06-30
0001655210
bynd:DistributorOneMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2019-01-01
2019-06-29
0001655210
bynd:DistributorOneMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-01-01
2018-06-30
0001655210
us-gaap:NonUsMember
us-gaap:SalesRevenueNetMember
us-gaap:GeographicConcentrationRiskMember
2018-04-01
2018-06-30
0001655210
us-gaap:SeriesEPreferredStockMember
2019-05-05
0001655210
bynd:DistributorOneMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-04-01
2018-06-30
0001655210
bynd:AdvisorAgreementMember
srt:AffiliatedEntityMember
2015-10-01
2015-10-31
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
us-gaap:CommonStockMember
2019-05-05
0001655210
srt:MinimumMember
bynd:AdvisorAgreementMember
srt:AffiliatedEntityMember
2015-10-01
2015-10-31
0001655210
bynd:DistributorTwoMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-04-01
2018-06-30
0001655210
bynd:DistributorTwoMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-01-01
2018-06-30
0001655210
us-gaap:ShippingAndHandlingMember
2019-03-31
2019-06-29
0001655210
bynd:DistributorThreeMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2018-04-01
2018-06-30
0001655210
us-gaap:ShippingAndHandlingMember
2018-01-01
2018-06-30
0001655210
us-gaap:SeriesBPreferredStockMember
2019-05-05
0001655210
bynd:DistributorTwoMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2019-03-31
2019-06-29
0001655210
us-gaap:SalesChannelDirectlyToConsumerMember
2018-01-01
2018-06-30
0001655210
us-gaap:SalesChannelThroughIntermediaryMember
2018-04-01
2018-06-30
0001655210
us-gaap:SalesChannelDirectlyToConsumerMember
2018-04-01
2018-06-30
0001655210
us-gaap:SalesChannelDirectlyToConsumerMember
2019-01-01
2019-06-29
0001655210
us-gaap:SalesChannelThroughIntermediaryMember
2018-01-01
2018-06-30
0001655210
us-gaap:SalesChannelThroughIntermediaryMember
2019-01-01
2019-06-29
0001655210
us-gaap:SalesChannelDirectlyToConsumerMember
2019-03-31
2019-06-29
0001655210
us-gaap:SalesChannelThroughIntermediaryMember
2019-03-31
2019-06-29
0001655210
bynd:CommonStockWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:PreferredStockWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:CommonStockWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:CommonStockWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:PreferredStockWarrantsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:PreferredStockWarrantsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:PreferredStockWarrantsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
bynd:CommonStockWarrantsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001655210
2019-01-02
2019-01-02
0001655210
bynd:DonaldThompsonMember
2019-01-01
2019-06-29
0001655210
srt:MinimumMember
bynd:AmendedAdvisorAgreementMember
srt:AffiliatedEntityMember
2016-12-01
2016-12-31
0001655210
us-gaap:ResearchAndDevelopmentExpenseMember
2019-03-31
2019-06-29
0001655210
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2018-04-01
2018-06-30
0001655210
us-gaap:CostOfSalesMember
2019-01-01
2019-06-29
0001655210
us-gaap:CostOfSalesMember
2018-04-01
2018-06-30
0001655210
us-gaap:CostOfSalesMember
2019-03-31
2019-06-29
0001655210
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-03-31
2019-06-29
0001655210
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-06-30
0001655210
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-06-29
0001655210
us-gaap:CostOfSalesMember
2018-01-01
2018-06-30
0001655210
us-gaap:ResearchAndDevelopmentExpenseMember
2018-04-01
2018-06-30
0001655210
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2018-01-01
2018-06-30
0001655210
us-gaap:ResearchAndDevelopmentExpenseMember
2019-01-01
2019-06-29
0001655210
us-gaap:VehiclesMember
2018-12-31
0001655210
us-gaap:EquipmentMember
2018-12-31
0001655210
us-gaap:AssetsHeldUnderCapitalLeasesMember
2019-06-29
0001655210
us-gaap:FurnitureAndFixturesMember
2018-12-31
0001655210
us-gaap:SoftwareAndSoftwareDevelopmentCostsMember
2019-06-29
0001655210
us-gaap:AssetUnderConstructionMember
2018-12-31
0001655210
bynd:ResearchAndDevelopmentEquipmentMember
2018-12-31
0001655210
us-gaap:LeaseholdImprovementsMember
2019-06-29
0001655210
us-gaap:AssetUnderConstructionMember
2019-06-29
0001655210
us-gaap:LeaseholdImprovementsMember
2018-12-31
0001655210
us-gaap:AssetsHeldUnderCapitalLeasesMember
2018-12-31
0001655210
us-gaap:VehiclesMember
2019-06-29
0001655210
bynd:ResearchAndDevelopmentEquipmentMember
2019-06-29
0001655210
us-gaap:EquipmentMember
2019-06-29
0001655210
us-gaap:FurnitureAndFixturesMember
2019-06-29
0001655210
us-gaap:SoftwareAndSoftwareDevelopmentCostsMember
2018-12-31
0001655210
us-gaap:SeriesBPreferredStockMember
2018-06-30
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:DebtInstrumentRedemptionPeriodThreeMember
us-gaap:LoansPayableMember
2018-06-30
0001655210
us-gaap:RevolvingCreditFacilityMember
us-gaap:DebtInstrumentRedemptionPeriodOneMember
us-gaap:LoansPayableMember
2018-06-30
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
us-gaap:CommonStockMember
2018-06-30
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:LineOfCreditMember
2019-06-29
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
2018-04-01
2018-06-30
0001655210
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2018-06-01
2018-06-30
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2018-01-01
2018-06-30
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2019-06-29
0001655210
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2018-06-01
2018-06-30
0001655210
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2019-06-29
0001655210
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2018-06-01
2018-06-30
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:DebtInstrumentRedemptionPeriodTwoMember
us-gaap:LoansPayableMember
2018-06-30
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2018-12-31
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
2019-03-31
2019-06-29
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2019-01-01
2019-06-29
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2019-03-31
2019-06-29
0001655210
bynd:EquipmentFinancingLoanMember
us-gaap:LoansPayableMember
2018-04-01
2018-06-30
0001655210
us-gaap:SeriesEPreferredStockMember
2018-06-30
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:DebtInstrumentRedemptionPeriodOneMember
us-gaap:LoansPayableMember
2018-06-30
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:DebtInstrumentRedemptionPeriodOneMember
us-gaap:LoansPayableMember
2018-06-01
2018-06-30
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
2019-01-01
2019-06-29
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:LoansPayableMember
2019-06-29
0001655210
bynd:SVBCreditFacilitiesMember
us-gaap:LineOfCreditMember
2018-01-01
2018-06-30
0001655210
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
2018-12-31
0001655210
bynd:A2018TermLoanFacilityMember
us-gaap:LoansPayableMember
2018-12-31
0001655210
2019-05-06
0001655210
2018-01-01
2018-12-31
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2018-12-31
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2019-01-01
2019-06-29
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2018-01-01
2018-12-31
0001655210
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-04-03
2019-04-03
0001655210
bynd:Beginning2020FiscalYearMember
bynd:A2018EquityIncentivePlanMember
2019-04-30
2019-04-30
0001655210
us-gaap:RestrictedStockMember
2019-03-31
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2018-12-31
0001655210
us-gaap:RestrictedStockMember
2018-10-31
0001655210
us-gaap:RestrictedStockMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
bynd:A2018EquityIncentivePlanMember
2019-04-18
0001655210
us-gaap:RestrictedStockMember
2019-06-29
0001655210
srt:ExecutiveOfficerMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-04-18
2019-04-18
0001655210
srt:MinimumMember
us-gaap:RestrictedStockMember
2018-10-01
2018-10-31
0001655210
us-gaap:RestrictedStockMember
2019-04-01
2019-04-30
0001655210
us-gaap:RestrictedStockMember
2019-04-30
0001655210
bynd:A2018EquityIncentivePlanMember
2018-12-31
0001655210
bynd:A2018EquityIncentivePlanMember
2011-04-11
2018-12-31
0001655210
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-04-29
2019-04-29
0001655210
us-gaap:RestrictedStockMember
2018-01-01
2018-06-30
0001655210
bynd:A2018EquityIncentivePlanMember
2019-04-30
0001655210
us-gaap:RestrictedStockUnitsRSUMember
bynd:A2018EquityIncentivePlanMember
2019-06-29
0001655210
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-06-10
0001655210
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-06-10
2019-06-10
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2018-04-01
2018-06-30
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2019-03-31
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2019-01-01
2019-06-29
0001655210
bynd:A2018EmployeeStockPurchasePlanMember
us-gaap:EmployeeStockMember
2018-11-15
2018-11-15
0001655210
us-gaap:RestrictedStockMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
bynd:A2018EquityIncentivePlanMember
2019-04-18
2019-04-18
0001655210
srt:ExecutiveOfficerMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-06-10
2019-06-10
0001655210
us-gaap:RestrictedStockUnitsRSUMember
2018-01-01
2018-06-30
0001655210
us-gaap:RestrictedStockMember
2019-01-01
2019-06-29
0001655210
srt:ExecutiveOfficerMember
us-gaap:ShareBasedPaymentArrangementEmployeeMember
bynd:A2018EquityIncentivePlanMember
2019-05-01
2019-05-01
0001655210
us-gaap:EmployeeStockOptionMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2019-01-01
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2019-03-31
2019-06-29
0001655210
us-gaap:RestrictedStockUnitsRSUMember
bynd:A2018EquityIncentivePlanMember
2018-12-31
0001655210
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2019-01-01
2019-06-29
0001655210
srt:MaximumMember
us-gaap:RestrictedStockMember
2018-10-01
2018-10-31
0001655210
bynd:A2018EquityIncentivePlanMember
2019-06-29
0001655210
bynd:A2018EmployeeStockPurchasePlanMember
us-gaap:EmployeeStockMember
2018-11-15
0001655210
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2019-01-01
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2018-01-01
2018-06-30
0001655210
us-gaap:RestrictedStockMember
2018-10-01
2018-10-31
0001655210
bynd:A2018EquityIncentivePlanMember
2011-04-11
2019-06-29
0001655210
us-gaap:RestrictedStockMember
2019-04-30
2019-04-30
0001655210
us-gaap:EmployeeStockOptionMember
2019-06-29
0001655210
us-gaap:EmployeeStockOptionMember
2018-04-01
2018-06-30
0001655210
us-gaap:RestrictedStockMember
2018-12-31
0001655210
us-gaap:RestrictedStockMember
2018-01-01
2018-12-31
0001655210
us-gaap:RestrictedStockMember
2018-04-01
2018-06-30
0001655210
us-gaap:EmployeeStockOptionMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2019-01-01
2019-06-29
0001655210
bynd:FormerCoManufacturerComplaintMember
us-gaap:PendingLitigationMember
2018-10-01
2018-10-31
iso4217:USD
xbrli:shares
xbrli:shares
xbrli:pure
iso4217:USD
bynd:defendant
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
| |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 |
For the quarterly period ended June 29, 2019
OR
|
| |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-38879
BEYOND MEAT, INC.
(Exact name of registrant as specified in its charter)
|
| |
Delaware | 26-4087597 |
(State or other jurisdiction of Incorporation or organization) | (I.R.S. Employer Identification No.) |
119 Standard Street
El Segundo, CA 90245
(Address, including zip code, of principal executive offices)
(866) 756-4112
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: |
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $0.0001 par value | | BYND | | The Nasdaq Stock Market, LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
|
| | | | | |
Large accelerated filer | | ☐ | Accelerated filer | | ☐ |
| | | | | |
Non-accelerated filer | | ☒ | Smaller reporting company | | ☐ |
| | | Emerging growth company | | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of July 26, 2019, the registrant had 60,178,252 shares of common stock, $0.0001 par value per share, outstanding.
Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of the federal securities laws. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the operating results and financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:
| |
• | estimates of our expenses, future revenues, capital requirements and our needs for additional financing; |
| |
• | our estimates of the size of our market opportunities; |
| |
• | our ability to effectively manage our growth; |
| |
• | our ability to effectively expand our manufacturing and production capacity; |
| |
• | our ability to successfully enter new markets, manage our international expansion and comply with any applicable laws and regulations; |
| |
• | the effects of increased competition from our market competitors; |
| |
• | the success of our marketing efforts and the ability to grow brand awareness and maintain, protect and enhance our brand; |
| |
• | our ability to maintain and effectively expand our relationships with key strategic restaurant and foodservice partners; |
| |
• | our ability to attract and retain our suppliers, distributors, co-manufacturers and customers; |
| |
• | our ability to procure sufficient high quality, raw materials to manufacture our products; |
| |
• | the availability of pea protein that meets our standards; |
| |
• | real or perceived quality or health issues with our products or other issues that adversely affect our brand and reputation; |
| |
• | changes in the tastes and preferences of our consumers; |
| |
• | significant disruption in, or breach in security of our information technology systems and resultant interruptions in service and any related impact on our reputation; |
| |
• | the attraction and retention of qualified employees and key personnel; |
| |
• | the effects of natural or man-made catastrophic events particularly involving our or any of our co-manufacturers’ manufacturing facilities or our suppliers’ facilities; |
| |
• | the effectiveness of our internal controls; |
| |
• | changes in laws and government regulation affecting our business, including Food and Drug Administration (“FDA”) governmental regulation and state regulation; |
| |
• | changes in laws, regulations or policies of governmental agencies or regulators relating to the labeling of our products; |
| |
• | the impact of adverse economic conditions; |
| |
• | the financial condition of, and our relationships with our suppliers, co-manufacturers, distributors, retailers and foodservice customers; |
| |
• | the ability of our suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations; |
| |
• | the sufficiency of our cash and cash equivalents to meet our liquidity needs and service our indebtedness; |
| |
• | economic conditions and their impact on consumer spending; |
| |
• | outcomes of legal or administrative proceedings; |
| |
• | our, our suppliers’ and our co-manufacturers’ ability to protect our proprietary technology and intellectual property adequately; |
as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements generally can be identified by words such as “believe,” “may,” “will,” “will continue,” “could,” “will likely result,” “estimate,” “continue,” “anticipate,” “intend,” “plan,” “predict,” “project,” “expect,” “potential” and similar expressions, as they relate to our company, our business and our management. These forward-looking statements are based on our current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those anticipated or implied in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Quarterly Report on Form 10-Q, including, without limitation, the risks discussed in Part II, Item 1A, "Risk Factors," and those discussed in other documents we file from time to time with the Securities and Exchange Commission (“SEC”).
Forward-looking statements speak only as of the date of this report. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
As used herein, the terms “Beyond Meat,” “we,” “us,” “our” and “the Company” refer to Beyond Meat, Inc., a Delaware corporation.
“Beyond Burger,” “Beyond Beef,” “Beyond Chicken,” “Beyond Meat,” “Beyond Sausage,” “Beyond Breakfast Sausage,” “The Cookout Classic,” “The Future of Protein” and “The Future of Protein Beyond Meat” and design are registered trademarks of Beyond Meat, Inc. in the United States and, in some cases, in certain other countries. All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective holders. Solely for convenience, the trademarks and trade names contained herein are referred to without the ® and TM symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.
Part I. Financial Information
ITEM I. FINANCIAL STATMENTS
BEYOND MEAT, INC.
Condensed Balance Sheets
(In thousands, except share and per share data)
(unaudited)
|
| | | | | | | |
| June 29, 2019 | | December 31, 2018 |
Assets | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 276,987 |
| | $ | 54,271 |
|
Accounts receivable | 34,388 |
| | 12,626 |
|
Inventory | 42,695 |
| | 30,257 |
|
Prepaid expenses and other current assets | 7,726 |
| | 5,672 |
|
Total current assets | 361,796 |
| | 102,826 |
|
Property, plant, and equipment, net | 34,473 |
| | 30,527 |
|
Other non-current assets, net | 792 |
| | 396 |
|
Total assets | $ | 397,061 |
| | $ | 133,749 |
|
Liabilities, Convertible Preferred Stock and Stockholders’ Equity (Deficit): | | | |
Current liabilities: | | | |
Accounts payable | $ | 27,383 |
| | $ | 17,247 |
|
Wages payable | 1,208 |
| | 1,255 |
|
Accrued bonus | 2,157 |
| | 2,312 |
|
Accrued expenses and other current liabilities | 3,622 |
| | 2,391 |
|
Short-term borrowings under revolving credit line | 6,000 |
| | — |
|
Short-term capital lease liabilities | 33 |
| | 44 |
|
Stock warrant liability | — |
| | 1,918 |
|
Total current liabilities | $ | 40,403 |
| | $ | 25,167 |
|
Long-term liabilities: | | | |
Revolving credit line | $ | — |
| | $ | 6,000 |
|
Long-term portion of bank term loan, net | 19,543 |
| | 19,388 |
|
Equipment loan, net | 4,924 |
| | 5,000 |
|
Capital lease obligations and other long-term liabilities | 406 |
| | 404 |
|
Total long-term liabilities | $ | 24,873 |
| | $ | 30,792 |
|
Commitments and Contingencies (Note 9) |
|
| |
|
|
|
| | | | | | | |
| June 29, 2019 | | December 31, 2018 |
Convertible preferred stock: | | | |
Series A convertible preferred stock, par value $0.0001 per share—no shares and 3,333,500 shares authorized, issued and outstanding as of June 29, 2019 and December 31, 2018 | $ | — |
| | $ | 2,000 |
|
Series B convertible preferred stock, par value $0.0001 per share—no shares and 4,802,260 shares authorized; no shares and 4,680,565 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 4,999 |
|
Series C convertible preferred stock, par value $0.0001 per share—no shares and 8,076,643 shares authorized; no shares and 8,076,636 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 14,882 |
|
Series D convertible preferred stock, par value $0.0001 per share—no shares and 8,713,207 shares authorized; no shares and 8,713,201 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 24,948 |
|
Series E convertible preferred stock, par value $0.0001 per share—no shares and 4,740,531 shares authorized; no shares and 4,701,449 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 17,214 |
|
Series F convertible preferred stock, par value $0.0001 per share—no shares and 4,866,776 shares authorized; no shares and 4,866,758 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 29,840 |
|
Series G convertible preferred stock, par value $0.0001 per share—no shares and 5,140,257 shares authorized; no shares and 5,114,786 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 55,658 |
|
Series H convertible preferred stock, par value $0.0001 per share—no shares and 4,209,693 shares authorized; no shares and 2,075,216 shares issued and outstanding as of June 29, 2019 and December 31, 2018 | — |
| | 49,999 |
|
Stockholders’ equity (deficit): | | | |
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding | — |
| | — |
|
Common stock, par value $0.0001 per share—500,000,000 shares and 58,669,600 shares authorized at June 29, 2019 and December 31, 2018, respectively; 60,167,521 and 6,951,350 shares issued and outstanding at June 29, 2019 and December 31, 2018, respectively | 6 |
| | 1 |
|
Additional paid-in capital | 477,541 |
| | 7,921 |
|
Accumulated deficit | (145,762 | ) | | (129,672 | ) |
Total stockholders’ equity (deficit) | $ | 331,785 |
| | $ | (121,750 | ) |
Total liabilities, convertible preferred stock and stockholders’ equity (deficit) | $ | 397,061 |
| | $ | 133,749 |
|
| | | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
BEYOND MEAT, INC.
Condensed Statements of Operations
(In thousands, except share and per share data)
(unaudited)
|
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Six Months Ended |
| | June 29, 2019 | | June 30, 2018 | | June 29, 2019 | | June 30, 2018 |
Net revenues | | $ | 67,251 |
| | $ | 17,367 |
| | $ | 107,457 |
| | $ | 30,143 |
|
Cost of goods sold | | 44,510 |
| | 14,755 |
| | 73,945 |
| | 25,474 |
|
Gross profit | | 22,741 |
| | 2,612 |
| | 33,512 |
| | 4,669 |
|
| | | | | | | | |
Research and development expenses | | 4,212 |
| | 2,497 |
| | 8,710 |
| | 4,102 |
|
Selling, general and administrative expenses | | 15,515 |
| | 7,043 |
| | 26,692 |
| | 12,780 |
|
Restructuring expenses | | 847 |
| | 348 |
| | 1,241 |
| | 642 |
|
Total operating expenses | | 20,574 |
| | 9,888 |
| | 36,643 |
| | 17,524 |
|
Income (loss) from operations | | 2,167 |
| | (7,276 | ) | | (3,131 | ) | | (12,855 | ) |
| | | | | | | | |
Other expense, net: | | | | | | | | |
Interest expense | | (741 | ) | | (28 | ) | | (1,474 | ) | | (75 | ) |
Remeasurement of warrant liability | | (11,744 | ) | | (130 | ) | | (12,503 | ) | | (259 | ) |
Other income, net | | 898 |
| | 38 |
| | 1,039 |
| | 97 |
|
Total other expense, net | | (11,587 | ) | | (120 | ) | | (12,938 | ) | | (237 | ) |
| | | | | | | | |
Loss before taxes | | (9,420 | ) | | (7,396 | ) | | (16,069 | ) | | (13,092 | ) |
Income tax expense | | 21 |
| | — |
| | 21 |
| | — |
|
Net loss | | $ | (9,441 | ) | | $ | (7,396 | ) | | $ | (16,090 | ) | | $ | (13,092 | ) |
Net loss per common share—basic and diluted | | $ | (0.24 | ) | | $ | (1.22 | ) | | $ | (0.69 | ) | | $ | (2.21 | ) |
Weighted average common shares outstanding—basic and diluted | | 39,081,359 |
| | 6,072,319 |
| | 23,206,203 |
| | 5,933,806 |
|
| | | | | | | | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
BEYOND MEAT, INC.
Condensed Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(In thousands, except share data)
(unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | | Common Stock | | Additional Paid-in Capital | | Accumulated Deficit | | Total |
| Shares | | Amount | | | Shares | | Amount | |
Balance at December 31, 2018 | 41,562,111 |
| | $ | 199,540 |
| | | 6,951,350 |
| | $ | 1 |
| | $ | 7,921 |
| | $ | (129,672 | ) | | $ | (121,750 | ) |
Net loss | — |
| | — |
| | | — |
| | — |
| | — |
| | (6,649 | ) | | (6,649 | ) |
Issuance of common stock through equity incentive plans | — |
| | — |
| | | 169,583 |
| | — |
| | 366 |
| | — |
| | 366 |
|
Share-based compensation | — |
| | — |
| | | — |
| | — |
| | 855 |
| | — |
| | 855 |
|
Balance March 29, 2019 | 41,562,111 |
| | $ | 199,540 |
| | | 7,120,933 |
| | $ | 1 |
| | $ | 9,142 |
| | $ | (136,321 | ) | | $ | (127,178 | ) |
Net loss | — |
| | — |
| | | — |
| | — |
| | — |
| | (9,441 | ) | | (9,441 | ) |
Issuance of common stock pursuant to the initial public offering, net of issuance costs of $4.9 million | — |
| | — |
| | | 11,068,750 |
| | 1 |
| | 252,452 |
| | — |
| | 252,453 |
|
Issuance of common stock upon conversion of convertible preferred stock | (41,562,111 | ) | | (199,540 | ) | | | 41,562,111 |
| | 4 |
| | 199,536 |
| | — |
| | 199,540 |
|
Issuance of common stock upon exercise of common stock warrants | — |
| | — |
| | | 214,875 |
| | — |
| | — |
| | — |
| | — |
|
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering | — |
| | — |
| | | — |
| | — |
| | 14,421 |
| | — |
| | 14,421 |
|
Issuance of common stock through equity incentive plans | — |
| | — |
| | | 200,852 |
| | — |
| | 167 |
| | — |
| | 167 |
|
Share-based compensation | — |
| | — |
| | | — |
| | — |
| | 1,823 |
| | — |
| | 1,823 |
|
Balance at June 29, 2019 | — |
| | $ | — |
| | | 60,167,521 |
| | $ | 6 |
| | $ | 477,541 |
| | $ | (145,762 | ) | | $ | 331,785 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | | Common Stock | | Additional Paid-in Capital | | Loans to Related Parties | | Accumulated Deficit | | Total |
| Shares | | Amount | | | Shares | | Amount | |
Balance at December 31, 2017 | 39,361,211 |
| | $ | 148,194 |
| | | 5,724,506 |
| | $ | 1 |
| | $ | 4,823 |
| | $ | (951 | ) | | $ | (99,786 | ) | | $ | (95,913 | ) |
Net loss | — |
| | — |
| | | — |
| | — |
| | — |
| | — |
| | (5,696 | ) | | (5,696 | ) |
Issuance of common stock through equity incentive plans | — |
| | — |
| | | 92,310 |
| | — |
| | 88 |
| | — |
| | — |
| | 88 |
|
Share-based compensation | — |
| | — |
| | | — |
| | — |
| | 260 |
| | — |
| | — |
| | 260 |
|
Issuance of Series G preferred stock, net of issuance costs of $7 | 112,945 |
| | 1,228 |
| | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
Balance at March 31, 2018 | 39,474,156 |
| | $ | 149,422 |
| | | 5,816,816 |
| | $ | 1 |
| | $ | 5,171 |
| | $ | (951 | ) | | $ | (105,482 | ) | | $ | (101,261 | ) |
Net loss | — |
| | — |
| | | — |
| | — |
| | — |
| | — |
| | (7,396 | ) | | (7,396 | ) |
Issuance of common stock through equity incentive plans | — |
| | — |
| | | 624,411 |
| | — |
| | 783 |
| | — |
| | — |
| | 783 |
|
Share-based compensation | — |
| | — |
| | | — |
| | — |
| | 450 |
| | — |
| | — |
| | 450 |
|
Issuance of Series G preferred stock, net of issuance costs of $19 | 12,739 |
| | 121 |
| | | — |
| | — |
| | . | | — |
| | — |
| | — |
|
Balance at June 30, 2018 | 39,486,895 |
| | $ | 149,543 |
| | | 6,441,227 |
| | $ | 1 |
| | $ | 6,404 |
| | $ | (951 | ) | | $ | (112,878 | ) | | $ | (107,424 | ) |
The accompanying notes are an integral part of these unaudited condensed financial statements.
BEYOND MEAT, INC.
Condensed Statements of Cash Flows
(In thousands)
(unaudited)
|
| | | | | | | | |
| | Six Months Ended |
| | June 29, 2019 | | June 30, 2018 |
Cash flows from operating activities: | | | | |
Net loss | | $ | (16,090 | ) | | $ | (13,092 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | |
Depreciation and amortization | | 3,957 |
| | 1,620 |
|
Share-based compensation expense | | 2,678 |
| | 710 |
|
Amortization of debt issuance costs | | 78 |
| | 35 |
|
Change in preferred and common stock warrant liabilities | | 12,503 |
| | 259 |
|
Net change in operating assets and liabilities: | | | | |
Accounts receivables | | (21,762 | ) | | (2,788 | ) |
Inventories | | (12,438 | ) | | (6,178 | ) |
Prepaid expenses and other assets | | (2,131 | ) | | (154 | ) |
Accounts payable | | 9,799 |
| | 6,623 |
|
Accrued expenses and other current liabilities | | 1,028 |
| | 259 |
|
Long-term liabilities | | 12 |
| | 39 |
|
Net cash used in operating activities | | $ | (22,366 | ) | | $ | (12,667 | ) |
Cash flows used in investing activities: | | | | |
Purchases of property, plant and equipment | | $ | (7,502 | ) | | $ | (9,973 | ) |
Proceeds from sale of fixed assets | | 232 |
| | — |
|
Purchases of property, plant and equipment held for sale | | (3,121 | ) | | — |
|
Payment of security deposits | | (487 | ) | | (60 | ) |
Net cash used in investing activities | | $ | (10,878 | ) | | $ | (10,033 | ) |
Cash flows from financing activities: | | | | |
Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs | | $ | 255,448 |
| | $ | — |
|
Proceeds from Series G preferred stock offering, net of offering costs | | — |
| | 1,350 |
|
Proceeds from bank term loan borrowing | | — |
| | 10,000 |
|
Repayments on revolving credit line | | — |
| | (2,500 | ) |
Repayment on term loan | | — |
| | (1,000 | ) |
Repayment of Missouri Note | | — |
| | (1,450 | ) |
Payments of capital lease obligations | | (21 | ) | | (117 | ) |
Proceeds from exercise of stock options | | 533 |
| | 871 |
|
Net cash provided by financing activities | | $ | 255,960 |
| | $ | 7,154 |
|
Net increase (decrease) in cash and cash equivalents | | $ | 222,716 |
| | $ | (15,546 | ) |
Cash and cash equivalents at the beginning of the period | | 54,271 |
| | 39,035 |
|
Cash and cash equivalents at the end of the period | | $ | 276,987 |
| | $ | 23,489 |
|
(continued on next page) |
|
| | | | | | | | |
| | Six Months Ended |
| | June 29, 2019 | | June 30, 2018 |
Supplemental disclosures of cash flow information: | | | | |
Cash paid during the period for: | | | | |
Interest | | $ | 1,445 |
| | $ | 63 |
|
Taxes | | $ | 21 |
| | $ | 3 |
|
Non-cash investing and financing activities: | | | | |
Capital lease obligations for the purchase of property, plant and equipment | | $ | — |
| | $ | 85 |
|
Issuance of convertible preferred stock warrants in connection with debt | | $ | — |
| | $ | 248 |
|
Non-cash additions to property, plant and equipment | | $ | 1,003 |
| | $ | 1,656 |
|
Deferred offering costs, accrued not yet paid | | $ | 578 |
| | $ | 64 |
|
Non-cash additions to property, plant and equipment held for sale | | $ | 646 |
| | $ | — |
|
Reclassification of warrant liability to additional paid-in capital in connection with the initial public offering | | $ | 14,421 |
| | $ | — |
|
Conversion of convertible preferred stock to common stock upon initial public offering | | $ | 199,540 |
| | $ | — |
|
(concluded) |
The accompanying notes are an integral part of these unaudited condensed financial statements.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements
Note 1. Introduction
The Company
Beyond Meat, Inc., a Delaware corporation (the “Company”), is one of the fastest growing food companies in the United States, offering a portfolio of revolutionary plant-based meats. The Company builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating the Company’s plant-based meat products. The Company’s brand commitment, “Eat What You Love,” represents a strong belief that by eating the Company’s plant-based meats, consumers can enjoy more, not less, of their favorite meals, and by doing so, help address concerns related to human health, climate change, resource conservation and animal welfare.
The Company’s primary production facilities are located in Columbia, Missouri, and research and development and administrative offices are located in El Segundo, California. In addition to its own production facilities, the Company uses co-manufacturers in various locations in the United States to manufacture its products. In May 2019, the Company partnered with one of its distributors to co-manufacture the Company’s products at a new manufacturing facility being constructed by this distributor in the Netherlands for estimated completion in 2020.
The Company sells to a variety of customers in the retail and foodservice channels throughout the United States and internationally through brokers and distributors. All of the Company’s long-lived assets are located in the United States.
Initial Public Offering
On May 6, 2019, the Company completed its initial public offering (“IPO”) of common stock, in which it sold 11,068,750 shares, including 1,443,750 shares pursuant to the underwriters’ over-allotment option. The shares began trading on the Nasdaq Global Select Market on May 2, 2019. The shares were sold at an IPO price of $25.00 per share for net proceeds of approximately $252.4 million, after deducting underwriting discounts and commissions of $19.4 million and offering expenses of approximately $4.9 million payable by the Company. Upon the closing of the IPO, all outstanding shares of the Company’s convertible preferred stock automatically converted into 41,562,111 shares of common stock on a one-for-one basis, and warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for a total of 160,767 shares of common stock.
Note 2. Summary of Significant Accounting Policies
Basis of Presentation
The unaudited condensed financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2019 or for any other interim period or for any other future fiscal year. These condensed financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the prospectus dated May 1, 2019 filed with the SEC on May 3, 2019 (the “Prospectus”). The condensed balance sheet as of December 31, 2018 has been derived from the audited financial statements at that date. There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the Prospectus, except as noted below.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
Fiscal Year
The Company operates on a fiscal calendar year, and each interim quarter is comprised of one 5-week period and two 4-week periods, with each week ending on a Saturday. The Company’s fiscal year always begins on January 1 and ends on December 31. As a result, the Company’s first and fourth fiscal quarters may have more or fewer days included than a traditional 91-day fiscal quarter.
Management’s Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion accruals; useful lives of property, plant and equipment; valuation of deferred tax assets; valuation of inventory; and the valuation of the fair value of common stock and preferred stock used to determine stock compensation expense and in the remeasurement of warrants and liabilities. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the condensed financial statements.
Reverse Stock Split
On January 2, 2019, the Company effected a 3-to-2 reverse stock split of its outstanding common stock and convertible preferred stock, including outstanding stock options and common and convertible preferred stock warrants. The reverse stock split did not result in an adjustment to par value. All references in the accompanying condensed financial statements and related notes to the number of shares of common stock, convertible preferred stock, warrants and options to purchase common stock and per share data reflect the effect of the reverse stock split.
Cash and Cash Equivalents
The Company maintains cash balances at one financial institution in the United States. The cash balances may, at times, exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation or FDIC up to $250,000. The Company considers all highly liquid investments with original maturity dates of 90 days or less to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market accounts.
Deferred Offering Costs
Offering costs, consisting primarily of legal, accounting, printing and filing services, and other direct fees and costs related to the IPO, were capitalized and offset against proceeds upon the consummation of the IPO. Total IPO issuance costs were $4.9 million, of which $2.4 million was incurred and paid as of December 31, 2018 and an additional $1.9 million was incurred and paid as of June 29, 2019. Approximately $0.6 million of IPO issuance costs incurred in the six months ended June 29, 2019 remained unpaid in accounts payable as of June 29, 2019.
Stock Warrant Liability
The Company accounts for freestanding warrants to purchase shares of its convertible preferred stock or common stock as a liability, as the underlying shares of convertible preferred stock and common stock are contingently redeemable and, therefore, may obligate the Company to transfer assets at some point in the future. The warrants were recorded at fair value upon issuance and are subject to remeasurement at each balance sheet date. Any change in fair value is recognized in the condensed statements of operations in Total other expense, net.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
Prior to the IPO, the Company had outstanding warrants to purchase an aggregate of 60,002 shares of its common stock at an exercise price of $3.00 per share, 121,694 shares of its Series B convertible preferred stock at an exercise price of $1.07 per share and 39,073 shares of its Series E convertible preferred stock at an exercise price of $3.68 per share. On May 6, 2019, in connection with the IPO, the warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for a total of 160,767 shares of common stock at the same respective exercise price per share. Subsequent to the closing of the IPO, all outstanding warrants to purchase shares of common stock were cashless exercised.
Fair Value of Financial Instruments
The fair value measurement accounting guidance creates a fair value hierarchy to prioritize the inputs used to measure fair value into three categories. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement, where Level 1 is the highest and Level 3 is the lowest.
The three levels are defined as follows:
| |
• | Level 1—Unadjusted quoted prices in active markets accessible by the reporting entity for identical assets or liabilities. Active markets are those in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
| |
• | Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which significant value drivers are observable. |
| |
• | Level 3—Valuations derived from valuation techniques in which significant value drivers are unobservable. |
The Company’s financial instruments include cash equivalents, accounts receivable, accounts payable, and accrued expenses, for which the carrying amounts approximate fair value due to the short-term maturity of these financial instruments. Based on the borrowing rates currently available to the Company for debt with similar terms, the carrying value of the line of credit, term debt with its bank, and equipment loan approximate fair value as well.
The Company had no financial instruments measured at fair value on a recurring basis as of June 29, 2019. Prior to the IPO, the stock warrant liability was measured at fair value using Level 3 inputs upon issuance and at each reporting date. Inputs used to determine the estimated fair value of the warrant liability as of the valuation date included expected term of the warrants, the risk-free interest rate, volatility, and the fair value of underlying shares.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis based on the fair value hierarchy as of December 31, 2018 (in thousands):
|
| | | | | | | | | | | | | | | |
| December 31, 2018 |
| Level 1 | | Level 2 | | Level 3 | | Total |
Financial Liabilities: | | | | | | | |
Preferred stock warrant liability | $ | — |
| | $ | — |
| | $ | 1,441 |
| | $ | 1,441 |
|
Common stock warrant liability | — |
| | — |
| | 477 |
| | 477 |
|
Total | $ | — |
| | $ | — |
| | $ | 1,918 |
| | $ | 1,918 |
|
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
The following table sets forth a summary of the changes in the fair value of the preferred and common stock warrant liabilities: |
| | | | | | | | |
| | For the Six Months Ended |
(in thousands) | | June 29, 2019 | | June 30, 2018 |
Beginning balance | | $ | 1,918 |
| | $ | 550 |
|
Fair value of warrants issued during the period | | — |
| | 248 |
|
Change in fair value of warrant liability | | 12,503 |
| | 259 |
|
Reclassification of warrant liability to additional paid-in capital in connection with the IPO | | (14,421 | ) | | — |
|
Ending balance | | $ | — |
| | $ | 1,057 |
|
The Company remeasured and reclassified the common stock warrant liability to additional paid-in-capital in connection with the IPO. Subsequent to the closing of the IPO, all outstanding warrants to purchase shares of common stock were cashless exercised and no warrants were outstanding as of June 29, 2019.
Revenue Recognition
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”), which, along with subsequent ASUs, amends the existing accounting standards for revenue recognition (“Topic 606”). This guidance is based on principles that govern the recognition of revenue at an amount an entity expects to be entitled to receive when products are transferred to customers. ASU 2014-09 was effective for the Company beginning January 1, 2019. The majority of the Company’s contracts with customers generally consist of a single performance obligation to transfer promised goods. Based on the Company’s evaluation process and review of its contracts with customers, the timing and amount of revenue recognized based on ASU 2014-09 is consistent with the Company’s revenue recognition policy under previous guidance. The Company has therefore concluded that the adoption of ASU 2014-09 did not have a material impact on its financial position, results of operations, or cash flows.
Revenue is recognized at the point in which the performance obligation under the terms of a contract with the customer have been satisfied and control has transferred. The Company’s performance obligation is typically defined as the accepted purchase order, or the contract, with the customer which requires the Company to deliver the requested products at agreed upon prices at the time and location of the customer’s choice. The Company does not offer warranties or a right to return on the products it sells except in the instance of a product recall.
Revenue is measured as the amount of consideration the Company expects to receive in exchange for fulfilling the performance obligation. Sales and other taxes the Company collects concurrent with the sale of products are excluded from revenue. The Company's normal payment terms vary by the type and location of its customers and the products offered. The time between invoicing and when payment is due is not significant. None of the Company's contracts as of June 29, 2019 contain a significant financing component.
The Company routinely offers sales discounts and promotions through various programs to its customers and consumers. These programs include rebates, temporary on shelf price reductions, off invoice discounts, retailer advertisements, and other trade activities. Provision for discounts and incentives are recorded in the same period in which the related revenues are recognized. At the end of each accounting period, the Company recognizes a liability for estimated sales discounts that have been incurred but not paid which totaled $1.1 million and $0.8 million as of June 29, 2019 and December 31, 2018, respectively. The offsetting charge is recorded as a reduction of revenues in the same period when the expense is incurred.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. The incremental cost to obtain contracts was not material.
The Company’s net revenues by platform and channel are included in the tables below: |
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | For the Six Months Ended |
(in thousands) | | June 29, 2019 | | June 30, 2018 | | June 29, 2019 | | June 30, 2018 |
Net revenues: | | | | | | | | |
Gross Fresh Platform | | $ | 67,722 |
| | $ | 15,119 |
| | $ | 106,528 |
| | $ | 24,715 |
|
Gross Frozen Platform | | 5,639 |
| | 4,506 |
| | 10,151 |
| | 9,254 |
|
Less: Discounts | | (6,110 | ) | | (2,258 | ) | | (9,222 | ) | | (3,826 | ) |
Net revenues | | $ | 67,251 |
| | $ | 17,367 |
| | $ | 107,457 |
| | $ | 30,143 |
|
|
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended | | For the Six Months Ended |
(in thousands) | | June 29, 2019 | | June 30, 2018 | | June 29, 2019 | | June 30, 2018 |
Net revenues: | | | | | | | | |
Retail | | $ | 34,120 |
| | $ | 11,684 |
| | $ | 53,699 |
| | $ | 20,972 |
|
Restaurant and Foodservice | | 33,131 |
| | 5,683 |
| | 53,758 |
| | 9,171 |
|
Net revenues | | $ | 67,251 |
| | $ | 17,367 |
| | $ | 107,457 |
| | $ | 30,143 |
|
Two distributors accounted for approximately 22% and 20%, respectively, of the Company’s gross revenues in the three months ended June 29, 2019; and three distributors accounted for approximately 39%, 15% and 15%, respectively, of the Company’s gross revenues in the three months ended June 30, 2018. Two distributors accounted for approximately 22% and 21%, respectively, of the Company’s gross revenues in the six months ended June 29, 2019; and three distributors accounted for approximately 37%, 15% and 13%, respectively, of the Company’s gross revenues in the six months ended June 30, 2018.
Approximately 12% of the Company’s net revenues in the three months ended June 29, 2019 was from international sales excluding sales in Canada as compared to approximately 3% in the three months ended June 30, 2018. Approximately 13% of the Company’s net revenues in the six months ended June 29, 2019 was from international sales excluding sales in Canada as compared to approximately 2% in the six months ended June 30, 2018. Net revenues from sales to the Canadian market are included with net revenues from sales to the United States market.
Shipping and Handling Costs
Outbound shipping and handling costs included in selling, general and administrative (“SG&A”) expenses in the three months ended June 29, 2019 and June 30, 2018 were $2.6 million and $1.8 million, respectively, and in the six months ended June 29, 2019 and June 30, 2018 were $3.9 million and $2.8 million, respectively.
Earnings (Loss) Per Share
Earnings (loss) per share (“EPS”) represents net income attributable to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS represents net income attributable to common stockholders divided by the weighted-average number of common shares outstanding, inclusive of the dilutive impact of potential common shares outstanding during the period. Such potential common shares include options, restricted stock units (“RSUs”), warrants and
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
convertible preferred stock. In periods when the Company records net loss, potential common shares are excluded in the computation of EPS because their inclusion would be anti-dilutive. See Note 11.
Related-Party Transactions
Seth Goldman
The Company entered into a consulting agreement with Seth Goldman, the Company’s Executive Chair, on March 2, 2016, which was amended and restated on November 15, 2018 and further amended on April 8, 2019. Pursuant to the consulting agreement, the Company will pay Mr. Goldman $20,210.33 per month for services rendered under the consulting agreement and, on the date of each annual meeting of the Company’s stockholders after which Mr. Goldman’s non-employee service on the board of directors will continue, the Company has agreed to grant Mr. Goldman a restricted stock unit award under the 2018 Equity Incentive Plan (the “Plan”), having a grant date fair value of $105,000. Each restricted stock unit grant will vest based on continued service in equal monthly installments over the 12-month period following the grant date, provided it will vest in full immediately prior to, and contingent upon, a change in control of the company.
The consulting agreement may be terminated by either party at any time upon 120 business days’ written notice. In the event of a default in the performance of the consulting agreement or material breach of any obligations under the consulting agreement, the non-breaching party may terminate the consulting agreement immediately if the breaching party fails to cure the breach within 30 business days after having received written notice by the non-breaching party of the default or breach.
Bernhard van Lengerich
The Company first entered into an advisor agreement with Food System Strategies, LLC in October 2015. Bernhard van Lengerich. Ph.D., a member of the Company’s Board of Directors, is the Chief Executive Officer of Food System Strategies, LLC. Pursuant to this advisor agreement, the Company paid Food System Strategies, LLC $4,000 for each day Dr. van Lengerich provided services, provided the Company paid Food System Strategies, LLC for at least two days of services per month. In February 2016, the Company entered into a new advisor agreement with Food System Strategies, LLC, which superseded the original agreement and provided for a $25,000 monthly retainer and a non-qualified stock option covering 798,848 shares, which vested in equal monthly installments over three years in consideration of Dr. van Lengerich providing services as the Company’s interim Chief Technical Officer and head of research and development, and the increased time commitment associated with these roles. In December 2016, the advisor agreement was amended to provide for a $10,000 monthly retainer to reflect the fact that Dr. van Lengerich would only be providing advisory services five to six days a month going forward. The advisor agreement may be terminated at any time upon written notice to the other party.
Donald Thompson
In the six months ended June 30, 2018, the Company incurred consulting costs payable to a company associated with Donald Thompson, a member of the Company’s Board of Directors, in the amount of $47,162. The Company did not incur any such consulting costs in the six months ended June 29, 2019.
Recently Adopted Accounting Pronouncements
In June 2018, the FASB issued ASU No. 2018-07, “Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). Under ASU 2018-07, the measurement of equity-classified nonemployee awards will be fixed at the grant date, and nonpublic entities are allowed to account for nonemployee awards using certain practical expedients that are already available for employee awards. The amendments in ASU 2018-07 are effective for nonpublic business entities for fiscal years beginning after December 15, 2019, and interim periods within fiscal
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
years beginning after December 15, 2020. Early adoption is permitted, but no earlier than the Company’s adoption date of Topic 606. The Company early adopted ASU 2018-07 beginning January 1, 2019 along with its adoption of ASU 2014-09. Pursuant to ASU 2018-07, the measurement of equity classified nonemployee awards will be fixed at the grant date, as compared to the previous requirement to remeasure the awards through the performance completion date.
New Accounting Pronouncements
As an “emerging growth company,” the Jumpstart Our Business Startups Act, or the JOBS Act, allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies.
In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”), which makes amendments to the guidance in GAAP on the classification and measurement of financial instruments. ASU 2016-01 significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. It also amends certain disclosure requirements associated with the fair value of financial instruments. For all entities other than public entities, ASU 2016-01 is effective for fiscal years beginning after December 15, 2018, including interim periods within fiscal years beginning after December 15, 2019. Early adoption is permitted. The Company expects to adopt and implement ASU 2016-01 for the year ending December 31, 2019 and for interim periods beginning January 1, 2020. The Company does not expect that adoption of ASU 2016-01 will have a material impact on the Company’s financial position, results of operations, or cash flows.
In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires lessees to generally recognize most operating leases on the balance sheets but record expenses on the income statements in a manner similar to current accounting. ASU 2016-02 along with subsequent ASU’s on Topic 842 is effective for nonpublic companies for the annual reporting period beginning after December 15, 2019, and, therefore, effective for the Company beginning January 1, 2020. Early application is permitted. The Company is currently evaluating the impact ASU 2016-02 will have on its financial statements and currently expects that most operating lease commitments will be subject to ASU 2016-02 and will be recognized as operating lease liabilities and right-of-use assets upon adoption. While the Company has not yet quantified the impact, adjustments resulting from the adoption of ASU 2016-02 will materially increase total assets and total liabilities relative to such amounts reported prior to adoption.
Note 3. Restructuring
In May 2017, management approved a plan to terminate the Company’s exclusive supply agreement (the “Agreement”) with one of its co-manufacturers, due to non-performance under the Agreement and on May 23, 2017, the Company notified the co-manufacturer of its decision to terminate the Agreement. In the three months ended June 29, 2019 and June 30, 2018, the Company recorded $0.8 million and $0.3 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. In the six months ended June 29, 2019 and June 30, 2018, the Company recorded $1.2 million and $0.6 million, respectively, in restructuring expenses related to this dispute, which consisted primarily of legal and other expenses. See Note 9 for further information. As of June 29, 2019 and December 31, 2018, there were no accrued unpaid liabilities associated with this contract termination.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
Note 4. Inventories
Major classes of inventory were as follows: |
| | | | | | | |
(in thousands) | June 29, 2019 | | December 31, 2018 |
Raw materials and packaging | $ | 25,047 |
| | $ | 13,756 |
|
Work in process | 5,635 |
| | 2,517 |
|
Finished goods | 12,013 |
| | 13,984 |
|
Total | $ | 42,695 |
| | $ | 30,257 |
|
Note 5. Property, Plant and Equipment
Property, plant, and equipment are stated at cost and capital lease assets are included. A summary of property, plant, and equipment as of June 29, 2019 and December 31, 2018, is as follows:
|
| | | | | | | | |
(in thousands) | | June 29, 2019 | | December 31, 2018 |
Manufacturing equipment | | $ | 29,783 |
| | $ | 25,314 |
|
Research and development equipment | | 7,373 |
| | 6,088 |
|
Leasehold improvements | | 7,337 |
| | 7,080 |
|
Capital leases | | 883 |
| | 882 |
|
Software | | 183 |
| | 60 |
|
Furniture and fixtures | | 364 |
| | 195 |
|
Vehicles | | 210 |
| | 210 |
|
Assets not yet placed in service | | 4,970 |
| | 3,374 |
|
Total property, plant and equipment | | $ | 51,103 |
| | $ | 43,203 |
|
Less: accumulated depreciation and amortization | | 16,630 |
| | 12,676 |
|
Property, plant and equipment, net | | $ | 34,473 |
| | $ | 30,527 |
|
Depreciation and amortization expense for the three months ended June 29, 2019 and June 30, 2018, was $2.1 million and $0.9 million, respectively. Of the total depreciation and amortization expense in the three months ended June 29, 2019 and June 30, 2018, $1.4 million and $0.7 million, respectively, were recorded in cost of goods sold and $0.6 million and $0.2 million, respectively, were recorded in research and development expenses, and $12,000 and $0, respectively, were recorded in SG&A expenses, in the Company’s condensed statements of operations.
Depreciation and amortization expense for the six months ended June 29, 2019 and June 30, 2018, was $4.0 million and $1.6 million, respectively. Of the total depreciation and amortization expense in the six months ended June 29, 2019 and June 30, 2018, $2.8 million and $1.3 million, respectively, were recorded in cost of goods sold and $1.1 million and $0.3 million, respectively, were recorded in research and development expenses, and $22,000 and $0, respectively, were recorded in SG&A expenses, in the Company’s condensed statements of operations.
The Company has $4.2 million and $1.0 million in property, plant and equipment concluded to meet the criteria for assets held for sale on the condensed balance sheets as of June 29, 2019 and December 31, 2018, respectively. The Company expects to sell such assets in 2019 for amounts that approximate book value.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
Note 6. Debt
The Company’s debt balances are detailed below:
|
| | | | | | | |
(in thousands) | June 29, 2019 | | December 31, 2018 |
2018 Revolving Credit Facility (defined below) | $ | 6,000 |
| | $ | 6,000 |
|
2018 Term Loan Facility (defined below) | 20,000 |
| | 20,000 |
|
Equipment financing loan | 5,000 |
| | 5,000 |
|
Debt issuance costs | (533 | ) | | (612 | ) |
Total debt outstanding | $ | 30,467 |
| | $ | 30,388 |
|
Less: current portion of long-term debt | 6,000 |
| | — |
|
Long-term debt | $ | 24,467 |
| | $ | 30,388 |
|
The Company records debt issuance costs as a reduction of carrying value of the debt in the accompanying condensed balance sheets. Debt issuance costs, net of amortization, totaled $0.5 million and $0.6 million as of June 29, 2019 and December 31, 2018, respectively. Debt issuance costs are amortized as interest expense over the term of the loan for which amortization of $20,000 and $26,000 was recorded during the three months ended June 29, 2019 and June 30, 2018, respectively, and $78,000 and $35,000 was recorded during the six months ended June 29, 2019 and June 30, 2018, respectively.
Amended and Restated Loan and Security Agreement
In June 2018, the Company refinanced its then existing revolving credit facility and term loan facility under a loan and security agreement with Silicon Valley Bank (“SVB”) (the “Amended LSA”). The Amended LSA includes a $6.0 million revolving credit facility (the “2018 Revolving Credit Facility”) and a term loan facility (the “2018 Term Loan Facility”) comprised of (i) a $10.0 million term loan advance at closing, (ii) a conditional $5.0 million term loan advance, if no event of default has occurred and is continuing through the borrowing date, and (iii) an additional conditional term loan advance of $5.0 million if no event of default has occurred and is continuing based upon a minimum level of gross profit for the trailing 12-month period. The 2018 Term Loan Facility has a floating interest rate that is equal to 4.0% above the prime rate, with interest payable monthly and principal amortizing commencing on January 1, 2020, and will mature in June 2022. Borrowings under the 2018 Revolving Credit Facility carry a variable annual interest rate of prime rate plus 0.75% to 1.25% with an additional 5% on the outstanding balances in the event of a default. The 2018 Revolving Credit Facility matures in June 2020.
The 2018 Term Loan Facility and the 2018 Revolving Credit Facility (the “SVB Credit Facilities,”) contain customary negative covenants that limit the Company’s ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets and merge or consolidate. The SVB Credit Facilities are secured by a blanket lien on all of the Company’s personal property assets. The SVB Credit Facilities also contain customary affirmative covenants, including delivery of audited financial statements. The Company was in compliance with the covenants in the SVB Credit Facilities as of June 29, 2019.
As of June 29, 2019 and December 31, 2018, the Company had $6.0 million and $20.0 million in borrowings on the 2018 Revolving Credit Facility and 2018 Term Loan Facility, respectively, and had no availability to borrow under either of these loan facilities. In the three months ended June 29, 2019 and June 30, 2018, the Company incurred $0.5 million and $22,000, respectively, in interest expense related to the SVB credit facilities. In the six months ended June 29, 2019 and June 30, 2018, the Company incurred $1.1 million and $40,000, respectively, in interest expense related to the SVB credit facilities. The interest rates on the 2018 Revolving Credit Facility and the 2018 Term Loan Facility at June 29, 2019 were 6.25% and 9.50%, respectively.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
Equipment Loan Facility
The Company had $5.0 million in borrowings outstanding as of June 29, 2019 and December 31, 2018 under the equipment loan facility. The interest rate on the equipment loan facility at June 29, 2019 and December 31, 2018 was 11.75% and 11.5%, respectively. For the three months ended June 29, 2019 and June 30, 2018, the Company recorded $0.2 million and $0, respectively, in interest expense related to the equipment loan facility. For the six months ended June 29, 2019 and June 30, 2018, the Company recorded $0.3 million and $0, respectively, in interest expense related to the equipment loan facility. The Company was in compliance with the covenants contained in the equipment loan facility as of June 29, 2019.
Warrant Liabilities
In connection with its financing arrangements, the Company issued warrants to purchase shares of its convertible preferred stock. For one of the financing arrangements, the Company issued warrants to purchase 121,694 shares of Series B convertible preferred stock at an exercise price of $1.07 per share. For a separate financing arrangement, the Company issued warrants to purchase 39,073 shares of Series E convertible preferred stock at an exercise price of $3.68 per share. In connection with the Company’s refinancing of its credit facilities with SVB, the Company issued to SVB and its affiliates warrants to purchase an aggregate of 60,002 shares of its common stock at an exercise price of $3.00 per share. Upon the closing of the IPO, the warrants exercisable for convertible preferred stock were automatically converted into warrants exercisable for a total of 160,767 shares of common stock at the same respective exercise price per share. Subsequent to the closing of the IPO, all outstanding warrants to purchase shares of common stock were cashless exercised and no warrants were outstanding as of June 29, 2019. See Note 2 for further information on the warrant liabilities.
Note 7. Stockholders’ Equity (Deficit) and Convertible Preferred Stock
Upon the closing of the IPO, all outstanding shares of the Company’s convertible preferred stock automatically converted into 41,562,111 shares of common stock on a one-for-one basis. On May 6, 2019, the Company filed an Amended and Restated Certificate of Incorporation authorizing the Company to issue 500,000,000 shares of common stock, $0.0001 par value per share, and 500,000 shares of undesignated preferred stock, $0.0001 par value per share, with rights and preferences determined by the Company’s Board of Directors at the time of issuance of such shares. As of June 29, 2019, the Company had 60,167,521 shares of common stock issued and outstanding.
As of December 31, 2018, the Company’s shares consisted of 58,669,600 authorized shares of common stock, par value $0.0001 per share, of which 6,951,350 shares were issued and outstanding, and 43,882,867 authorized shares of preferred stock, par value $0.0001 per share, of which 3,333,500 shares of Series A Preferred Stock, 4,680,565 shares of Series B Preferred Stock, 8,076,636 shares of Series C Preferred Stock, 8,713,201 shares of Series D Preferred Stock, 4,701,449 shares of Series E Preferred Stock, 4,866,758 shares of Series F Preferred Stock, 5,114,786 shares of Series G Preferred Stock and 2,075,216 shares of Series H Preferred Stock were issued and outstanding.
The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock.
Note 8. Share-Based Compensation
On April 11, 2011, the Company’s stockholders approved the 2011 Equity Incentive Plan (“2011 Plan”), and most recently amended the 2011 Plan on April 10, 2019. The 2011 Plan was amended, restated and re-named the 2018 Equity Incentive Plan (“2018 Plan”), which became effective as of April 30, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO.
BEYOND MEAT, INC.
Notes to Unaudited Condensed Financial Statements (continued)
The remaining shares available for issuance under the 2011 Plan were added to the shares reserved for issuance under the 2018 Plan.
The 2018 Plan provides for the grant of stock options (including incentive stock options and non-qualified stock options), stock appreciation rights, restricted stock, RSUs, performance units, and performance shares to the Company’s employees, directors, and consultants. The maximum aggregate number of shares that may be issued under the 2018 Plan is 14,482,356 shares of the Company’s common stock. In addition, the number of shares reserved for issuance under the 2018 Plan will be increased automatically on the first day of each fiscal year beginning with the 2020 fiscal year, by a number equal to the least of: (i) 2,144,521 shares; (ii) 4.0% of the shares of common stock outstanding on the last day of the prior fiscal year; or (iii) such number of shares determined by the Company’s Board of Directors.
The 2018 Plan may be amended, suspended or terminated by the Company’s Board of Directors at any time, provided such action does not impair the existing rights of any participant, subject to stockholder approval of any amendment to the 2018 Plan as required by applicable law or listing requirements. Unless sooner terminated by the Company’s Board of Directors, the 2018 Plan will automatically terminate on November 14, 2028.
The following grants were made pursuant to the 2018 Plan in the six months ended June 29, 2019: (i) options to purchase 264,033 shares of common stock were granted to certain employees on April 3, 2019, having an exercise price of $20.02 per share, (ii) options to purchase (A) 1,000,000 shares of common stock were granted to executive officers on April 18, 2019, (B)